These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38089042)

  • 41. n-Butyrate mediation of ganglioside expression of human and murine cancer cells demonstrates relative cell specificity.
    Berenson CS; Patterson MA; Miqdadi JA; Lance P
    Clin Sci (Lond); 1995 Apr; 88(4):491-9. PubMed ID: 7789051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
    Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T
    J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
    Gillard BK; Thomas JW; Nell LJ; Marcus DM
    J Immunol; 1989 Jun; 142(11):3826-32. PubMed ID: 2654294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurostatin and other O-acetylated gangliosides show anti-neuroinflammatory activity involving the NFκB pathway.
    Yanguas-Casás N; Ojalvo-Sanz AC; Martínez-Vázquez A; Goneau MF; Gilbert M; Nieto-Sampedro M; Romero-Ramírez L
    Toxicol Appl Pharmacol; 2019 Aug; 377():114627. PubMed ID: 31202640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gangliosides in nervous system development, regeneration, and pathologies.
    Vasques JF; de Jesus Gonçalves RG; da Silva-Junior AJ; Martins RS; Gubert F; Mendez-Otero R
    Neural Regen Res; 2023 Jan; 18(1):81-86. PubMed ID: 35799513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of gangliosides in brain development and the potential benefits of perinatal supplementation.
    Ryan JM; Rice GE; Mitchell MD
    Nutr Res; 2013 Nov; 33(11):877-87. PubMed ID: 24176227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Ying and Yang of Ganglioside Function in Cancer.
    Schengrund CL
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gangliosides in T cell development and function of mice.
    Inokuchi JI; Nagafuku M
    Glycoconj J; 2022 Apr; 39(2):229-238. PubMed ID: 35156158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody.
    Hayashi N; Chiba H; Kuronuma K; Go S; Hasegawa Y; Takahashi M; Gasa S; Watanabe A; Hasegawa T; Kuroki Y; Inokuchi J; Takahashi H
    Cancer Sci; 2013 Jan; 104(1):43-7. PubMed ID: 23004020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role(s) of gangliosides in neural differentiation and repair: a perspective.
    Schengrund CL
    Brain Res Bull; 1990 Jan; 24(1):131-41. PubMed ID: 2178726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered 9-O acetylation of disialogangliosides in cerebellar Purkinje cells of the nervous mutant mouse.
    Yamamoto M; Schwarting GA; Crandall JE
    Brain Res; 1994 Oct; 662(1-2):223-32. PubMed ID: 7859075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines.
    Livingston PO
    Immunol Rev; 1995 Jun; 145():147-66. PubMed ID: 7590824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-system disorders of glycosphingolipid and ganglioside metabolism.
    Xu YH; Barnes S; Sun Y; Grabowski GA
    J Lipid Res; 2010 Jul; 51(7):1643-75. PubMed ID: 20211931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.
    Sipione S; Monyror J; Galleguillos D; Steinberg N; Kadam V
    Front Neurosci; 2020; 14():572965. PubMed ID: 33117120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immune-mediated neuropathy and anti-glycolipid antibodies].
    Kaida K; Kusunoki S
    Brain Nerve; 2013 Apr; 65(4):413-23. PubMed ID: 23568989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.
    Fernández LE; Alonso DF; Gomez DE; Vázquez AM
    Expert Rev Vaccines; 2003 Dec; 2(6):817-23. PubMed ID: 14711364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gangliosides in Cancer Cell Signaling.
    Groux-Degroote S; Rodríguez-Walker M; Dewald JH; Daniotti JL; Delannoy P
    Prog Mol Biol Transl Sci; 2018; 156():197-227. PubMed ID: 29747814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification and structural characterization of de-N-acetylated form of GD3 ganglioside present in human melanoma tumors.
    Popa I; Pons A; Mariller C; Tai T; Zanetta JP; Thomas L; Portoukalian J
    Glycobiology; 2007 Apr; 17(4):367-73. PubMed ID: 17242043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.